Orthobiologics Market Size, Share, Growth Analysis, By Product(Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein), By Application(Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery), By End User(Hospitals, Orthopedic Clinics, & Ambulatory Care Centers), By Region - Industry Forecast 2024-2031

Geographically, North America dominated the market in 2023 and is expected to lead over the forecast period owing to the presence of improved healthcare infrastructure, growing cases of musculoskeletal issues, and strong research and growing number of research and developments. North America brags about its developed healthcare infrastructure with easy access to superior technologies and well-trained professionals. Regional growth is also impacted by the rising number of sports patients that report sports injuries and osteoarthritis issues. This majorly demands improved and innovative treatments. Furthermore, increasing amount of research and development fuels modernizations in orthobiologics, resulting in the emergence of novel therapies. The key players profiled in the region include Amgen Inc., Medtronic, Zimmer Biomet, Stryker Corporation, Amedica Corporation, Bone Therapeutics, and more.    

Europe is the fastest-growing region in the global orthobiologics market due to strong research and innovation, regulatory support, and the growing aging population. Europe is the leading center for several universities and research institutes that emphasize orthobiologics and regenerative medicines, which drives developments and innovations. The region also holds supportive frameworks that streamline the selling and approval of novel products, thus impacting market growth. Furthermore, the growing senior population in Europe is majorly impacting the demand for orthopedic-associated surgeries and the need for more effective procedures.